We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
story of the week
Published in Renal Cell Carcinoma

Journal Scan / Research · December 10, 2019

Nivolumab for the Treatment of Patients With Metastatic Non–Clear Cell Renal Cell Carcinoma

The Oncologist

 

Additional Info

The Oncologist
Nivolumab for the Treatment of Patients With Metastatic Non-Clear Cell Renal Cell Carcinoma (nccRCC): A Single-Institutional Experience and Literature Meta-Analysis
Oncologist 2019 Sep 09;[EPub Ahead of Print], J Chahoud, P Msaouel, MT Campbell, T Bathala, L Xiao, J Gao, AJ Zurita, AY Shah, E Jonasch, P Sharma, NM Tannir

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading